Gingival crevicular fluid biochemical markers in periodontal disease: A cross-sectional study

Autor(es)

Perozini, Caroline ^[1] ; Chibebe, Priscilla C. A. ^{[1, 2]} ; Pereira Leao, Mariella Vieira ; Queiroz, Celso da Silva ^{[3, 1]} ; Pallos, Debora ^[1]

Afiliação do(s) autor(es)

^[1] Univ Taubate, Fac Dent, Dept Periodont, Taubate - Brazil

^[2] Univ Taubate, Inst Basico Biociencias, Taubate - Brazil

^[3] Paulista Univ UNIP, Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Quintessence International; v. 41, n. 10, p. 877-883, NOV-DEC 2010.
• Citações Web of Science: 17

Resumo

Objective: To evaluate the levels of interleukin-1 beta (IL-1 beta) and alkaline phosphatase (ALP) in gingival crevicular fluid (GCF) and correlate these measurements with clinical characteristics of healthy patients and patients with gingivitis and periodontitis. Method and Materials: Thirty-six individuals were subdivided into three groups of 12: control, gingivitis, and periodontitis groups. GCF samples were obtained from 2 sites for each patient. GCF volume was measured with the Periotron 8000; IL-1 beta levels were evaluated using the ELISA technique; ALP was measured by the kinetic method. Results: Mean levels of IL-1 beta and ALP in the 3 groups were, respectively, 22.34 +/- 16.53 mu L/site and 7.68 +/- 2.46 U/L in the control group; 41.46 +/- 27.98 mu L/site and 9.80 +/- 1.53 U/L in the gingivitis group; and 105.97 +/- 89.26 mu L/site and 11.56 +/- 1.82 U/L in the periodontitis group. The amount of IL-1 beta in the periodontitis group was significantly higher than in the other groups, but no significant difference was found between the control group and the gingivitis group. The amount of ALP differed significantly among the 3 groups (P < .05). A positive correlation was observed among IL-1 beta levels, GCF volume, and probing depth. There was no evidence for a correlation between IL-1 beta and ALP levels. Conclusion: Monitoring immune markers may give additional information on healthy or diseased sites. (Quintessence Int 2010; 41: 877-883) (AU)

• Processo FAPESP: 02/12891-2 - Avaliacao dos niveis de interleucina 1b em pacientes com doenca periodontal na menopausa e com diabetes tipo ii.
• Beneficiário: Débora Pallos
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 05/59393-5 - Avaliacao dos niveis de interleucina 1 beta na doenca periodontal.
• Beneficiário: Caroline Perozini
• Modalidade de apoio: Bolsas no Brasil - Iniciação Científica